Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kress

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Hematologic Malignancy Reports|June 3, 2017
Therapeutic Options for Aggressive T-Cell LymphomasJennifer K Lue, Anna Kress, Jennifer E Amengual
American Journal of Clinical Pathology|August 20, 2023
Warm autoantibodies mimicking alloantibodies: Three cases of autoantibodies with unusual antigenic specificityJeremy W Jacobs, Thomas C Binns, Elizabeth Abels, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 2, 2024
Providing 0.1 Full-Time Equivalent (FTE) Support to Fellowship Core Faculty Improves Faculty Involvement in Fellowship Education and RecruitmentAyesha Butt, Jana Christian, Anna Kress, et al.
Nature Communications|October 19, 2019
Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantationMedini K Annavajhala, Angela Gomez-Simmonds, Nenad Macesic, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 13, 2016
Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney DiseaseJeffrey J Weiss, Ioannis Konstantinidis, Anna Boueilh, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 28, 2026
Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin LymphomaDaniel Ermann, Victoria Vardell, Erin Zacholski, et al.
Blood Advances|August 27, 2024
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional seriesNarendranath Epperla, Adam S Zayac, Daniel J Landsburg, et al.
Journal of Hematology & Oncology|July 16, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort studyNarendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Blood Advances|May 12, 2023
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective studyAdam S Zayac, Daniel J Landsburg, Mitchell E Hughes, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Hematologic Malignancy Reports|June 3, 2017
Therapeutic Options for Aggressive T-Cell LymphomasJennifer K Lue, Anna Kress, Jennifer E Amengual
American Journal of Clinical Pathology|August 20, 2023
Warm autoantibodies mimicking alloantibodies: Three cases of autoantibodies with unusual antigenic specificityJeremy W Jacobs, Thomas C Binns, Elizabeth Abels, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 2, 2024
Providing 0.1 Full-Time Equivalent (FTE) Support to Fellowship Core Faculty Improves Faculty Involvement in Fellowship Education and RecruitmentAyesha Butt, Jana Christian, Anna Kress, et al.
Nature Communications|October 19, 2019
Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantationMedini K Annavajhala, Angela Gomez-Simmonds, Nenad Macesic, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 13, 2016
Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney DiseaseJeffrey J Weiss, Ioannis Konstantinidis, Anna Boueilh, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 28, 2026
Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin LymphomaDaniel Ermann, Victoria Vardell, Erin Zacholski, et al.
Blood Advances|August 27, 2024
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional seriesNarendranath Epperla, Adam S Zayac, Daniel J Landsburg, et al.
Journal of Hematology & Oncology|July 16, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort studyNarendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Blood Advances|May 12, 2023
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective studyAdam S Zayac, Daniel J Landsburg, Mitchell E Hughes, et al.
Pageof 1